As the world remains anxious for innovative tools to tackle the coronavirus, drugmaker Glenmark Pharmaceuticals expects the antiviral nasal spray from SaNOtize to be available in India in three months.
Read more here.
As the world remains anxious for innovative tools to tackle the coronavirus, drugmaker Glenmark Pharmaceuticals expects the antiviral nasal spray from SaNOtize to be available in India in three months.
Read more here.
![[yulife in City A.M.] The founder of Yulife on avoiding the grey-suit mentality of the insurance industry](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
